Home > > > > Report Detail

Global Typhoid Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 100
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Typhoid Vaccine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Typhoid Vaccine market. Further, it explains the major drivers and regional dynamics of the global Typhoid Vaccine market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Sanofi

- Merck

- GlaxoSmithKline

- PaxVax

- Actiza Pharmaceutical

- Merit Pharmaceuticals

- Bharat Biotec

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Typhoid Vaccine Segment by Type

- Oral Type Typhoid Vaccine

- Injection Type Typhoid Vaccine

Typhoid Vaccine Segment by Application

- Hospital

- Research & Academic Laboratories

- Pharmaceutical & Biotechnology Companies

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Typhoid Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Typhoid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Typhoid Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Typhoid Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Typhoid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Typhoid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Typhoid Vaccine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical, Merit Pharmaceuticals and Bharat Biotec, etc.

Global Typhoid Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Typhoid Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Oral Type Typhoid Vaccine
1.2.3 Injection Type Typhoid Vaccine
1.3 Market Segment by Application
1.3.1 Global Typhoid Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Typhoid Vaccine Market Size (2017-2028)
2.1.1 Global Typhoid Vaccine Revenue (2017-2028)
2.1.2 Global Typhoid Vaccine Sales (2017-2028)
2.2 Global Typhoid Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Typhoid Vaccine Sales by Regions (2017-2022)
2.2.2 Global Typhoid Vaccine Revenue by Regions (2017-2022)
2.3 Global Typhoid Vaccine Market Size Forecast by Region
2.3.1 Global Typhoid Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Typhoid Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Typhoid Vaccine Regions (Countries) Ranking by Market Size
2.5 Typhoid Vaccine Market Dynamics
2.5.1 Typhoid Vaccine Market Trends
2.5.2 Typhoid Vaccine Market Drivers
2.5.3 Typhoid Vaccine Market Challenges
2.5.4 Typhoid Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Typhoid Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Typhoid Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Typhoid Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Typhoid Vaccine Sales in 2021
3.2 Global Top Manufacturers Typhoid Vaccine by Revenue
3.2.1 Global Typhoid Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Typhoid Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Typhoid Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Typhoid Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Typhoid Vaccine as of 2021)
3.4 Global Typhoid Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Typhoid Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Typhoid Vaccine Market
3.7 Key Manufacturers Typhoid Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Typhoid Vaccine Market Size by Type
4.1 Global Typhoid Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Typhoid Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Typhoid Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Typhoid Vaccine Price by Type (2017-2022)
4.2 Global Typhoid Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Typhoid Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Typhoid Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Typhoid Vaccine Price Forecast by Type (2023-2028)
5 Global Typhoid Vaccine Market Size by Application
5.1 Global Typhoid Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Typhoid Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Typhoid Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Typhoid Vaccine Price by Application (2017-2022)
5.2 Global Typhoid Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Typhoid Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Typhoid Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Typhoid Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Typhoid Vaccine Sales Breakdown by Company
6.1.1 North America Typhoid Vaccine Sales by Company (2017-2022)
6.1.2 North America Typhoid Vaccine Revenue by Company (2017-2022)
6.2 North America Typhoid Vaccine Market Size by Type
6.2.1 North America Typhoid Vaccine Sales by Type (2017-2028)
6.2.2 North America Typhoid Vaccine Revenue by Type (2017-2028)
6.3 North America Typhoid Vaccine Market Size by Application
6.3.1 North America Typhoid Vaccine Sales by Application (2017-2028)
6.3.2 North America Typhoid Vaccine Revenue by Application (2017-2028)
6.4 North America Typhoid Vaccine Market Size by Country
6.4.1 North America Typhoid Vaccine Sales by Country (2017-2028)
6.4.2 North America Typhoid Vaccine Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Typhoid Vaccine Sales Breakdown by Company
7.1.1 Europe Typhoid Vaccine Sales by Company (2017-2022)
7.1.2 Europe Typhoid Vaccine Revenue by Company (2017-2022)
7.2 Europe Typhoid Vaccine Market Size by Type
7.2.1 Europe Typhoid Vaccine Sales by Type (2017-2028)
7.2.2 Europe Typhoid Vaccine Revenue by Type (2017-2028)
7.3 Europe Typhoid Vaccine Market Size by Application
7.3.1 Europe Typhoid Vaccine Sales by Application (2017-2028)
7.3.2 Europe Typhoid Vaccine Revenue by Application (2017-2028)
7.4 Europe Typhoid Vaccine Market Size by Country
7.4.1 Europe Typhoid Vaccine Sales by Country (2017-2028)
7.4.2 Europe Typhoid Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Typhoid Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Typhoid Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Typhoid Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Typhoid Vaccine Market Size by Type
8.2.1 Asia Pacific Typhoid Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Typhoid Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Typhoid Vaccine Market Size by Application
8.3.1 Asia Pacific Typhoid Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Typhoid Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Typhoid Vaccine Market Size by Region
8.4.1 Asia Pacific Typhoid Vaccine Sales by Region
8.4.2 Asia Pacific Typhoid Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Typhoid Vaccine Sales Breakdown by Company
9.1.1 Latin America Typhoid Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Typhoid Vaccine Revenue by Company (2017-2022)
9.2 Latin America Typhoid Vaccine Market Size by Type
9.2.1 Latin America Typhoid Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Typhoid Vaccine Revenue by Type (2017-2028)
9.3 Latin America Typhoid Vaccine Market Size by Application
9.3.1 Latin America Typhoid Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Typhoid Vaccine Revenue by Application (2017-2028)
9.4 Latin America Typhoid Vaccine Market Size by Country
9.4.1 Latin America Typhoid Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Typhoid Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Typhoid Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Typhoid Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Typhoid Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Typhoid Vaccine Market Size by Type
10.2.1 Middle East and Africa Typhoid Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Typhoid Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Typhoid Vaccine Market Size by Application
10.3.1 Middle East and Africa Typhoid Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Typhoid Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Typhoid Vaccine Market Size by Country
10.4.1 Middle East and Africa Typhoid Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Typhoid Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Typhoid Vaccine Products and Services
11.1.5 Sanofi Typhoid Vaccine SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Typhoid Vaccine Products and Services
11.2.5 Merck Typhoid Vaccine SWOT Analysis
11.2.6 Merck Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Typhoid Vaccine Products and Services
11.3.5 GlaxoSmithKline Typhoid Vaccine SWOT Analysis
11.3.6 GlaxoSmithKline Recent Developments
11.4 PaxVax
11.4.1 PaxVax Corporation Information
11.4.2 PaxVax Overview
11.4.3 PaxVax Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 PaxVax Typhoid Vaccine Products and Services
11.4.5 PaxVax Typhoid Vaccine SWOT Analysis
11.4.6 PaxVax Recent Developments
11.5 Actiza Pharmaceutical
11.5.1 Actiza Pharmaceutical Corporation Information
11.5.2 Actiza Pharmaceutical Overview
11.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Actiza Pharmaceutical Typhoid Vaccine Products and Services
11.5.5 Actiza Pharmaceutical Typhoid Vaccine SWOT Analysis
11.5.6 Actiza Pharmaceutical Recent Developments
11.6 Merit Pharmaceuticals
11.6.1 Merit Pharmaceuticals Corporation Information
11.6.2 Merit Pharmaceuticals Overview
11.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Merit Pharmaceuticals Typhoid Vaccine Products and Services
11.6.5 Merit Pharmaceuticals Typhoid Vaccine SWOT Analysis
11.6.6 Merit Pharmaceuticals Recent Developments
11.7 Bharat Biotec
11.7.1 Bharat Biotec Corporation Information
11.7.2 Bharat Biotec Overview
11.7.3 Bharat Biotec Typhoid Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Bharat Biotec Typhoid Vaccine Products and Services
11.7.5 Bharat Biotec Typhoid Vaccine SWOT Analysis
11.7.6 Bharat Biotec Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Typhoid Vaccine Value Chain Analysis
12.2 Typhoid Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Typhoid Vaccine Production Mode & Process
12.4 Typhoid Vaccine Sales and Marketing
12.4.1 Typhoid Vaccine Sales Channels
12.4.2 Typhoid Vaccine Distributors
12.5 Typhoid Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Typhoid Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Type Typhoid Vaccine
Table 3. Major Manufacturers of Injection Type Typhoid Vaccine
Table 4. Global Typhoid Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Typhoid Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Typhoid Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Typhoid Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Typhoid Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Typhoid Vaccine Revenue Market Share by Region (2017-2022)
Table 10. Global Typhoid Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Typhoid Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Typhoid Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Typhoid Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Typhoid Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Typhoid Vaccine Market Trends
Table 16. Typhoid Vaccine Market Drivers
Table 17. Typhoid Vaccine Market Challenges
Table 18. Typhoid Vaccine Market Restraints
Table 19. Global Typhoid Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Typhoid Vaccine Sales Share by Manufacturers (2017-2022)
Table 21. Global Typhoid Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Typhoid Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 23. Typhoid Vaccine Revenue Share by Manufacturers (2017-2022)
Table 24. Global Typhoid Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Typhoid Vaccine as of 2021)
Table 26. Key Manufacturers Typhoid Vaccine Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Typhoid Vaccine Plants/Factories Distribution
Table 28. Key Manufacturers Typhoid Vaccine Area Served
Table 29. Date of Key Manufacturers Enter into Typhoid Vaccine Market
Table 30. Key Manufacturers Typhoid Vaccine Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Typhoid Vaccine Sales (K Units) by Type (2017-2022)
Table 33. Global Typhoid Vaccine Sales Share by Type (2017-2022)
Table 34. Global Typhoid Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Typhoid Vaccine Price (K Units) by Type (2017-2022)
Table 36. Global Typhoid Vaccine Sales (K Units) by Type (2023-2028)
Table 37. Global Typhoid Vaccine Sales Share by Type (2023-2028)
Table 38. Global Typhoid Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Typhoid Vaccine Revenue Share by Type (2023-2028)
Table 40. Global Typhoid Vaccine Price (K Units) by Type (2023-2028)
Table 41. Global Typhoid Vaccine Sales (K Units) by Application (2017-2022)
Table 42. Global Typhoid Vaccine Sales Share by Application (2017-2022)
Table 43. Global Typhoid Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Typhoid Vaccine Price (K Units) by Application (2017-2022)
Table 45. Global Typhoid Vaccine Sales (K Units) by Application (2023-2028)
Table 46. Global Typhoid Vaccine Sales Share by Application (2023-2028)
Table 47. Global Typhoid Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Typhoid Vaccine Revenue Share by Application (2023-2028)
Table 49. Global Typhoid Vaccine Price (K Units) by Application (2023-2028)
Table 50. North America Typhoid Vaccine Sales by Company (2017-2022) & (K Units)
Table 51. North America Typhoid Vaccine Sales Market Share by Company (2017-2022)
Table 52. North America Typhoid Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Typhoid Vaccine Revenue Market Share by Company (2017-2022)
Table 54. North America Typhoid Vaccine Sales by Type (2017-2022) & (K Units)
Table 55. North America Typhoid Vaccine Sales by Type (2023-2028) & (K Units)
Table 56. North America Typhoid Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Typhoid Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Typhoid Vaccine Sales by Application (2017-2022) & (K Units)
Table 59. North America Typhoid Vaccine Sales by Application (2023-2028) & (K Units)
Table 60. North America Typhoid Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Typhoid Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Typhoid Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. North America Typhoid Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. North America Typhoid Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Typhoid Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Typhoid Vaccine Sales by Company (2017-2022) & (K Units)
Table 67. Europe Typhoid Vaccine Sales Market Share by Company (2017-2022)
Table 68. Europe Typhoid Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Typhoid Vaccine Revenue Market Share by Company (2017-2022)
Table 70. Europe Typhoid Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Europe Typhoid Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Europe Typhoid Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Typhoid Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Typhoid Vaccine Sales by Application (2017-2022) & (K Units)
Table 75. Europe Typhoid Vaccine Sales by Application (2023-2028) & (K Units)
Table 76. Europe Typhoid Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Typhoid Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Typhoid Vaccine Sales by Country (2017-2022) & (K Units)
Table 79. Europe Typhoid Vaccine Sales by Country (2023-2028) & (K Units)
Table 80. Europe Typhoid Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Typhoid Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Typhoid Vaccine Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Typhoid Vaccine Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Typhoid Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Typhoid Vaccine Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Typhoid Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Typhoid Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Typhoid Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Typhoid Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Typhoid Vaccine Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Typhoid Vaccine Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Typhoid Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Typhoid Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Typhoid Vaccine Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Typhoid Vaccine Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Typhoid Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Typhoid Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Typhoid Vaccine Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Typhoid Vaccine Sales Market Share by Company (2017-2022)
Table 100. Latin America Typhoid Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Typhoid Vaccine Revenue Market Share by Company (2017-2022)
Table 102. Latin America Typhoid Vaccine Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Typhoid Vaccine Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Typhoid Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Typhoid Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Typhoid Vaccine Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Typhoid Vaccine Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Typhoid Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Typhoid Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Typhoid Vaccine Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Typhoid Vaccine Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Typhoid Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Typhoid Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Typhoid Vaccine Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Typhoid Vaccine Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Typhoid Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Typhoid Vaccine Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Typhoid Vaccine Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Typhoid Vaccine Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Typhoid Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Typhoid Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Typhoid Vaccine Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Typhoid Vaccine Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Typhoid Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Typhoid Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Typhoid Vaccine Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Typhoid Vaccine Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Typhoid Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Typhoid Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Sanofi Typhoid Vaccine Product and Services
Table 134. Sanofi Typhoid Vaccine SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. Merck Corporation Information
Table 137. Merck Description and Overview
Table 138. Merck Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Merck Typhoid Vaccine Product and Services
Table 140. Merck Typhoid Vaccine SWOT Analysis
Table 141. Merck Recent Developments
Table 142. GlaxoSmithKline Corporation Information
Table 143. GlaxoSmithKline Description and Overview
Table 144. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. GlaxoSmithKline Typhoid Vaccine Product and Services
Table 146. GlaxoSmithKline Typhoid Vaccine SWOT Analysis
Table 147. GlaxoSmithKline Recent Developments
Table 148. PaxVax Corporation Information
Table 149. PaxVax Description and Overview
Table 150. PaxVax Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. PaxVax Typhoid Vaccine Product and Services
Table 152. PaxVax Typhoid Vaccine SWOT Analysis
Table 153. PaxVax Recent Developments
Table 154. Actiza Pharmaceutical Corporation Information
Table 155. Actiza Pharmaceutical Description and Overview
Table 156. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Actiza Pharmaceutical Typhoid Vaccine Product and Services
Table 158. Actiza Pharmaceutical Typhoid Vaccine SWOT Analysis
Table 159. Actiza Pharmaceutical Recent Developments
Table 160. Merit Pharmaceuticals Corporation Information
Table 161. Merit Pharmaceuticals Description and Overview
Table 162. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Merit Pharmaceuticals Typhoid Vaccine Product and Services
Table 164. Merit Pharmaceuticals Typhoid Vaccine SWOT Analysis
Table 165. Merit Pharmaceuticals Recent Developments
Table 166. Bharat Biotec Corporation Information
Table 167. Bharat Biotec Description and Overview
Table 168. Bharat Biotec Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Bharat Biotec Typhoid Vaccine Product and Services
Table 170. Bharat Biotec Typhoid Vaccine SWOT Analysis
Table 171. Bharat Biotec Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Typhoid Vaccine Distributors List
Table 175. Typhoid Vaccine Customers List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Vaccine Product Picture
Figure 2. Global Typhoid Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. Oral Type Typhoid Vaccine Product Picture
Figure 4. Injection Type Typhoid Vaccine Product Picture
Figure 5. Global Typhoid Vaccine Sales Market Share by Application in 2021 & 2028
Figure 6. Hospital Use Case
Figure 7. Research & Academic Laboratories Use Case
Figure 8. Pharmaceutical & Biotechnology Companies Use Case
Figure 9. Others Use Case
Figure 10. Typhoid Vaccine Report Years Considered
Figure 11. Global Typhoid Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Typhoid Vaccine Market Size 2017-2028 (US$ Million)
Figure 13. Global Typhoid Vaccine Sales (2017-2022) & (K Units)
Figure 14. Global Typhoid Vaccine Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Typhoid Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Typhoid Vaccine Sales Market Share by Region in 2021
Figure 17. Global Typhoid Vaccine Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Typhoid Vaccine Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Typhoid Vaccine Sales in 2021
Figure 20. Typhoid Vaccine Revenue Share by Manufacturers in 2021
Figure 21. Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Typhoid Vaccine Revenue Share by Type (2017-2022)
Figure 23. Global Typhoid Vaccine Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Typhoid Vaccine Revenue Share by Application (2017-2022)
Figure 25. Global Typhoid Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Typhoid Vaccine Sales Market Share by Type (2017-2028)
Figure 27. North America Typhoid Vaccine Revenue Market Share by Type (2017-2028)
Figure 28. North America Typhoid Vaccine Sales Market Share by Application (2017-2028)
Figure 29. North America Typhoid Vaccine Revenue Market Share by Application (2017-2028)
Figure 30. North America Typhoid Vaccine Sales Share by Country (2017-2028)
Figure 31. North America Typhoid Vaccine Revenue Share by Country (2017-2028)
Figure 32. U.S. Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Typhoid Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Europe Typhoid Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Europe Typhoid Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Europe Typhoid Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. Europe Typhoid Vaccine Sales Share by Country (2017-2028)
Figure 39. Europe Typhoid Vaccine Revenue Share by Country (2017-2028)
Figure 40. Germany Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. France Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 42. U.K. Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 43. Italy Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 44. Russia Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Asia Pacific Typhoid Vaccine Sales Market Share by Type (2017-2028)
Figure 46. Asia Pacific Typhoid Vaccine Revenue Market Share by Type (2017-2028)
Figure 47. Asia Pacific Typhoid Vaccine Sales Market Share by Application (2017-2028)
Figure 48. Asia Pacific Typhoid Vaccine Revenue Market Share by Application (2017-2028)
Figure 49. Asia Pacific Typhoid Vaccine Sales Share by Region (2017-2028)
Figure 50. Asia Pacific Typhoid Vaccine Revenue Share by Region (2017-2028)
Figure 51. China Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Japan Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. South Korea Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. India Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. Australia Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. China Taiwan Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. Indonesia Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Thailand Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Malaysia Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Latin America Typhoid Vaccine Sales Market Share by Type (2017-2028)
Figure 61. Latin America Typhoid Vaccine Revenue Market Share by Type (2017-2028)
Figure 62. Latin America Typhoid Vaccine Sales Market Share by Application (2017-2028)
Figure 63. Latin America Typhoid Vaccine Revenue Market Share by Application (2017-2028)
Figure 64. Latin America Typhoid Vaccine Sales Share by Country (2017-2028)
Figure 65. Latin America Typhoid Vaccine Revenue Share by Country (2017-2028)
Figure 66. Mexico Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Brazil Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Argentina Typhoid Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Middle East and Africa Typhoid Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Typhoid Vaccine Revenue Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Typhoid Vaccine Sales Market Share by Application (2017-2028)
Figure 72. Middle East and Africa Typhoid Vaccine Revenue Market Share by Application (2017-2
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs